Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-13-000121
Filing Date
2013-02-14
Accepted
2013-02-14 17:20:40
Documents
1
Period of Report
2013-02-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ss165380_4.html 4  
1 OWNERSHIP DOCUMENT ss165380_4.xml 4 13498
  Complete submission text file 0000947871-13-000121.txt   16007
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
ISALY SAMUEL D (Reporting) CIK: 0001055949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 13616063

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 13616064

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED CAPITAL GP II LLC (Reporting) CIK: 0001281668 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 13616060

Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations